Posts Tagged ‘Stem Cell Technology’

April 18 2010

A Study of Cord Blood Preservation

The first cord blood transplant was performed in 1988. Since then, more than 8,000 transplants have occurred.Families know that there is only one opportunity – at birth – to collect these genetically unique stem cells and if not taken, the cord blood is simply discarded.This technology to collect and store newborn’s umbilical cord blood stem cells has only been widely available since late 1995.Currently, thousands of parents are taking advantage of this once-in-a-lifetime opportunity. Cord blood stem cells are showing significant potential to treat conditions that have no cure today – like juvenile diabetes and brain injury.

It is recommended to preserve Cord Blood as a type of biological insurance as these stem cells can be a life saver at a later stage. Check out the complete list of dieseases cured by cord blood.Our baby’s cord blood may offer a lifetime of protection:

  • Ready availability of a treatment method using Cord Blood when needed, and faster treatment is always better.
  • For treating cancers and blood disorders in transplant medicine, having the family’s own cord blood available has many advantage as it reduces complications.
  • The baby’s cord blood may be used to treat many diseases including leukemia, other cancers, and blood disorders.
  • Regenerative medicine therapies using cord blood, the child’s own stem cells are required.
  • Potential to treat conditions that have no cure today – like juvenile diabetes and brain injury.
  • Ready availability of a treatment method using Cord Blood when needed, and faster treatment is always better.

Some families have more defined risk factors, but most families bank for the security of knowing the health benefits that stem cells may someday offer their children, themselves, or other family members.

Is it the right time to invest in Cord Blood Preservation?

Recently Cord Blood America in Las Vegas has received lot of news coverage and is traded publically since 2003.

CBAI, moving toward achieving its goal of becoming a globally dominant stem cell storage company, recently signed a deal licensing its umbilical cord blood technology to AXM Pharma Inc., a China pharmaceutical and nutraceutical company.

Cord Blood America is located at Las Vegas and currently is the largest cryogenic storage in the world. Currently US, Russia, China, Japan, and Europe are the leaders in Cryogenic technology.

Cryogenic pertains to liquefied gases, ie, helium, nitrogen, CO2, which are all inert and extremely cold, ie. -270 deg. Celsius. Others are reactive, LP, Hydrogen.

Information from Guide of Stem Cell Technology